Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

New functional magnetic resonance imaging (MRI) studies appear to show higher lesion counts and greater lesion volumes exist in primary progressive multiple sclerosis (PPMS) patients who are...

In a large-scale, genome-wide analysis of more than 110,000 samples, a worldwide consortium of scientists has identified 200 genetic loci associated with MS. Their findings were presented in a...

According to a recent update on the Univadis website, patient-reported quality-of-life variables showed a preference for dimethyl fumarate compared to Fingolimod. Head-to-head trials comparing of...

Individuals with relapsing-remitting multiple sclerosis (RRMS) and an inadequate response to prior disease modifying therapies had a greater level of confirmed disability improvement (CDI) and a...

ExoAtlet, a Skolkovo startup that makes medical exoskeletons for the rehabilitation of disabled people, has started clinical research into the use of its exoskeletons to help people with multiple...

UK-based drug discovery firm Apitope Technology says it has regained global rights to its product, ATX-MS-1467, from Germany’s Merck KGaA (MRK: DE).

Apitope, a wholly-owned subsidiary of...

Chronic conditions including asthma and multiple sclerosis could be inflamed by a type of protein found in wheat, scientists have claimed...

Mouse experiments with compounds having opposite actions on two receptors for tumour necrosis factor (TNF) — a key factor in neurodegeneration — explains why earlier trials of TNF blockers in...

Low dose naltrexone (LDN) appears to be safe for patients with multiple sclerosis even when taken long term. A paper...

UK researchers say the MS drug alemtuzumab (Lemtrada) may help reverse some of the physical disability caused by multiple sclerosis if it is taken early enough.

The study is published in...

Pages

Live Chat Software by Click4Assistance UK